Font Size: a A A

Value Of Tumor Fading Rate Of Induction Chemotherapy As An Early Biomarker Predictor Of Patient's Outcome In Locally Advance Nasopharyngeal Carcinoma

Posted on:2021-01-05Degree:MasterType:Thesis
Country:ChinaCandidate:J XuFull Text:PDF
GTID:2404330602485133Subject:Oncology
Abstract/Summary:PDF Full Text Request
Objective:To explore whether the tumor fading rate after induction chemotherapy can be used to evaluate the prognosis of patients with locally advanced nasopharyngeal carcinoma.Methods:A retrospective analysis was performed on 220 patients with locally advanced nasopharyngeal carcinoma,histologically diagnosed,stage III-IVa,previously untreated ? All patients received 2 cycles induction chemotherapy,followed by concurrent chemoradiotherapy.We performed in all patients before and after induction chemotherapy of nasopharyngeal and neck imaging examination,and calculate the primary tumors and neck lymph nodes volume before and after induction chemotherapy,according to the(pre-GTV-post-GTV)÷ pre-GTV x 100% to calculate the percentage of tumor regression,and use SPSS 25.0 statistical software for data analysis,analyze the correlation with 5-year local recurrence-free survival(LRFS),distant metastasis-free survival(DMFS),disease progression-free survival(PFS),and overall survival(OS),respectively.Results:The primary tumor fading rate of patients after induced chemotherapy was significant associated with LRFS(P =0.022),DMFS(P=0.022),and was not correlated with PFS(P =0.378),OS(P =0.412),while thelymph node tumor fading rate was not correlated with LRFS(P =0.841),DMFS(P =0.841),PFS(P =0.727),and OS(P =0.596).The ROC characteristic curve analysis was used to calculate the optimal cut-off values of the primary tumor fading rate,LRFS,DMFS,PFS and OS,23.47%(AUC=67.5%),23.47%(AUC=67.5%),31.06%(AUC=52.9%)and 50.76%(AUC=67.5%),respectively.According to the optimal cut-off values divided the patients into tumor fading rate < optimal cutoff value vs tumor fading rate > optimal cutoff value,Kaplan-meier survival analysis for patients with 5-year LRFS(P <0.001),DMFS(P <0.001),and OS(P =0.027),while the primary tumor fading rate was not correlated with 5-year PFS(P =0.107).Conclusion:The volume regression rate of primary nasopharyngeal carcinoma was greater than 23.47%,23.47%,31.06% and 50.76%,and the5-year LRFS,DMFS,PFS and OS were significantly better than those less than the above regression rate?The lymph node tumor fading rate was not correlated with LRFS,DMFS,PFS and OS?...
Keywords/Search Tags:nasopharyngeal carcinoma, induction chemotherapy, tumor fading rate, prognostic prediction, biomarker
PDF Full Text Request
Related items
Prognostic Analysis Of Different Cycles Of Induction Chemotherapy For Locally Advanced Nasopharyngeal Carcinoma,and The Exploration On The Efficacy And Safety Of Sequential Adjuvant Chemotherapy Following Radiotherapy Combined With Induction Chemotherapy
TPF And GP Induction Chemotherapy Combined With Concurrent Chemoradiotherapy In Locally Advanced Nasopharyngeal Carcinoma
Prognostic Value Of Serum Uric Acid And Tumor Response To Induction Chemotherapy In Locally Advanced Nasopharyngeal Carcinoma
Predicting The Efficacy Of Induction Chemotherapy For Locally Advanced Nasopharyngeal Carcinoma Based On MRI Radiomics Of Cervical Lymph Nodes
Clinical Research Of Induction Chemotherapy Followed By Concurrent Chemoradiotherapy For Locally Advanced(T3-4/N+) Nasopharyngeal Carcinoma
The Treatment Outcome Effects Of Changing Target Delineation Of Intensity Modulated Radiotherapy After Induction Chemotherapy For Advanced Nasopharyngeal Carcinoma: One Prospective Multi-center Randomized Controlled Clinical Trial
Comparison Of The Clinical Efficiacy Of TPF Induction Chemotherapy With Different Dose Intense For Locally Advanced Nasopharyngeal Carcinoma
Matched Analysis Of Induction Chemotherapy Plus Chemoradiotherapy Versus Induction Chemotherapy Plus Radiotherapy Alone In Locoregionally Advanced Nasopharyngeal Carcinoma: A Clinical Study
A Retrospective Study Of Chemoradiotherapy Combined With Induction Chemotherapy And/or Adjuvant Chemotherapy In The Treatment Of Locally Advanced Nasopharyngeal Carcinoma
10 Analysis Of Clinical Characteristics, Treatment Strategy And Prognostic Facters Of 352 Patients With Nasopharyngeal Carcinoma